Amgen : AMGN

All Amgen Articles

699 Articles

Jon C. Ogg | Jun 28, 2012 at 10:38 AM EDT

Supreme Court Rules on Healthcare, The Fallout By Sector (Updated)

Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and…

Jon C. Ogg | Jun 13, 2012 at 8:38 AM EDT

The 2012 Dividend Sinners: 20 Companies That Don’t Pay Dividends But Should

24/7 Wall St. loves companies which send capital back to shareholders via dividends. With all of the uncertainty in today’s…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 8, 2012 at 1:15 PM EDT

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a…

Jon C. Ogg | Apr 20, 2012 at 2:35 PM EDT

Top Earnings Previews For Early In The Week Ahead (COP, ILMN, NFLX, TXN, AMGN, AAPL, T, BIDU, COH, JNPR, MMM, RF, X, UTX)

Earnings season is in full swing and we have many key reports due in the coming week. 24/7 Wall St.…

Paul Ausick | Mar 21, 2012 at 12:46 PM EDT

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As…

Douglas A. McIntyre | Mar 6, 2012 at 4:54 PM EST

How America’s Richest Companies Invest Their Cash

You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 billion…

Paul Ausick | Mar 6, 2012 at 4:05 PM EST

24/7 Wall St. Closing Bell (GOOG, YNDX, LULU, AMGN, NLY, BDE, FTEK, HK, PAY, DKS, IRDM, SSI, MTN, VRML, EBTX, XOMA, ONTY, ZLTQ)

The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all…

Jon C. Ogg | Mar 6, 2012 at 8:09 AM EST

Top Analyst Upgrades & Downgrades (AMGN, NLY, GPC, GOOG, LPNT, LULU, NUAN, SUN, YHOO, YNDX)

Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Jon C. Ogg | Feb 13, 2012 at 4:17 PM EST

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …

Paul Ausick | Feb 9, 2012 at 4:07 PM EST

24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)

The three major US stock indexes opened a bit higher this morning, and after some volatility have managed to get…

Jon C. Ogg | Feb 9, 2012 at 8:29 AM EST

Top Analyst Upgrades & Downgrades (AMGN, AUO, AONE, ELN, EXPE, IR, MMM, MRH, NYX, POST, RIMM, SOHU, AAPL)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Paul Ausick | Feb 8, 2012 at 2:24 PM EST

Amgen Fails in Bid to Expand Use of Cancer Drug (AMGN)

A US drug advisory panel today denied by a 12-1 vote permission for Amgen Inc. (NASDAQ: AMGN) to market its…

Jon C. Ogg | Feb 8, 2012 at 7:59 AM EST

Credit Suisse Chooses Biogen Idec Over Amgen (BIIB, AMGN)

Credit Suisse is making a change in its Global Biotechnology outlook and says the is ‘room to run on generalist…

Paul Ausick | Jan 31, 2012 at 4:06 PM EST

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…

1 … 35 36 37 38 39 … 47

Amgen : AMGN

All Amgen Articles

Supreme Court Rules on Healthcare, The Fallout By Sector (Updated)

The 2012 Dividend Sinners: 20 Companies That Don’t Pay Dividends But Should

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

Top Earnings Previews For Early In The Week Ahead (COP, ILMN, NFLX, TXN, AMGN, AAPL, T, BIDU, COH, JNPR, MMM, RF, X, UTX)

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

How America’s Richest Companies Invest Their Cash

24/7 Wall St. Closing Bell (GOOG, YNDX, LULU, AMGN, NLY, BDE, FTEK, HK, PAY, DKS, IRDM, SSI, MTN, VRML, EBTX, XOMA, ONTY, ZLTQ)

Top Analyst Upgrades & Downgrades (AMGN, NLY, GPC, GOOG, LPNT, LULU, NUAN, SUN, YHOO, YNDX)

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)

Top Analyst Upgrades & Downgrades (AMGN, AUO, AONE, ELN, EXPE, IR, MMM, MRH, NYX, POST, RIMM, SOHU, AAPL)

Amgen Fails in Bid to Expand Use of Cancer Drug (AMGN)

Credit Suisse Chooses Biogen Idec Over Amgen (BIIB, AMGN)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Amgen : AMGN

All Amgen Articles

Supreme Court Rules on Healthcare, The Fallout By Sector (Updated)

The 2012 Dividend Sinners: 20 Companies That Don’t Pay Dividends But Should

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

Top Earnings Previews For Early In The Week Ahead (COP, ILMN, NFLX, TXN, AMGN, AAPL, T, BIDU, COH, JNPR, MMM, RF, X, UTX)

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

How America’s Richest Companies Invest Their Cash

24/7 Wall St. Closing Bell (GOOG, YNDX, LULU, AMGN, NLY, BDE, FTEK, HK, PAY, DKS, IRDM, SSI, MTN, VRML, EBTX, XOMA, ONTY, ZLTQ)

Top Analyst Upgrades & Downgrades (AMGN, NLY, GPC, GOOG, LPNT, LULU, NUAN, SUN, YHOO, YNDX)

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)

Top Analyst Upgrades & Downgrades (AMGN, AUO, AONE, ELN, EXPE, IR, MMM, MRH, NYX, POST, RIMM, SOHU, AAPL)

Amgen Fails in Bid to Expand Use of Cancer Drug (AMGN)

Credit Suisse Chooses Biogen Idec Over Amgen (BIIB, AMGN)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do